Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Abstract Text:

,

This article presents a classification system for patients with the spectrum of clinical and laboratory findings attributable to human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). This classification system is primarily for public health purposes, including disease reporting and surveillance, epidemiologic studies, prevention and control activities, and public health policy and planning. The system classifies the manifestations of HTLV-III/LAV infection into 4 groups: I) patients with transient signs and symptoms that appear at the time of, or shortly after, initial infection with HTLV-III/LAV as identified by laboratory studies; II) patients with no signs or symptoms of HTLV-III/LAV infection, who in turn can be subclassified on the basis of whether hematologic and/or immunologic studies have been done and whether results are abnormal; III) patients with persistent generalized lymphadenopathy at 2 or more extra-inguinal sites persisting for more than 3 months in the absence of a condition other than HTLV-III/LAV infection to explain these findings; and IV) patients with clinical symptoms and signs of HTLV-III/LAV infection other than or in addition to lymphadenopathy. Patients in Group IV are further categorized into 5 subgroups: A) constitutional disease, B) neurologic disease, C) secondary infectious disease, D) secondary cancers, and E) other conditions resulting from HTLV-III/LAV infection. This classificatory system will require periodic revision as new information about HTLV-III/LAV infection is accumulated. Patients whose clinical presentations fulfill the surveillance definition of acquired immunedeficiency syndrome (AIDS) should be classified in Group IV.

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Publishing Authors By Initials

,

For similar virus diseases: rna virus infections: retroviridae infections research abstracts see: virus diseases: rna virus infections: retroviridae infections research

PUBMED ID PMID:

MEDLINE DATE:

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: MMWR. Morbidity and mortality weekly report

VOLUME: 35

Page Numbers: 334-9

Journal Abbreviation: MMWR Morb. Mortal. Wkly. Rep.

ISSN: 0149-2195

DAY: 23

MONTH: May

YEAR: 1986

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7802429

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Keywords Mesh Terms:

KEYWORDS: Retroviridae Infections

MESH TERMS: classification

Chemical & Substance for Abstract: Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: MMWR Morb Mortal Wkly Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections Related Publications